The only preclinical imaging platform allowing for fast in vivo screening of SPECT and alpha-emitting isotope radiopharmaceuticals
Features
- Small animal, SPECT and alpha-emitting isotope live imaging platform
- Real time, whole body imaging since time zero post injection
- Fast screening of radiolabeled compounds
- User interchangeable collimators for optimizing parameters on a wide range of applications
- Compatible with 3rd party anesthesia and Vital Signs monitoring system
- Extended version available, for up to 4 mice or 1 rat imaging
Performance
- Weight less than 50kg
- Dimensions: 43cm (L) x 46cm (W) x 43cm (H)
- <2mm spatial resolution
- Down to 10 sec frames for whole body scans
- Energy resolution down to 19%
- Detectable energy range 35-500 keV
Definition of a user friendly platform
- Straightforward workflow with easy imaging protocol set-up
- Plain to operate by non highly-experienced professionals
- Footprint allowing for simple system installation and transfer
- Ideal for imaging inside a clean room, or next to a cyclotron
- Visual | eyesTM software hub for post processing of imaging data
Applications
Oncology, Alpha Emitters
[225]Ac imaging using γ-eye™
In vivo imaging of alpha-emitting isotopes made possible, with BIOEMTECH technology. Two illustrative images, from two timepoints: 2h and 24h post injection with a Ac-225 radiopharmaceutical, in an oncology model. Scan duration 10 min. Dose injected: 3.5 uCi / 0.13 Mbq. Images acquired at Radiomedix laboratories.
Looking for more info on the γ-eye™ and its applications?
Download the γ-eye™ Brochure